Bupivacaine Hydrochloride + Dextrose interactions
Checked as Bupivacaine + Dextrose, unspecified form in this data source.
Full monograph for Bupivacaine Hydrochloride + DextroseCheck it against another medicine
Medicines
215 documented
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Articaine Hydrochloride + Epinephrine Bitartratevia Bupivacaine | Major | Synergy · Unknown | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as…2 documented mechanisms | 3 sources — open the full entry |
| Beclomethasone Dipropionate + Chloramphenicol + Clotrimazole + Lidocainevia Bupivacaine | Major | Synergy · Unknown | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as…2 documented mechanisms | 3 sources — open the full entry |
| Benzocaine + Butamben + Tetracaine Hydrochloridevia Bupivacaine | Major | Synergy | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as…2 documented mechanisms | 10 sources — open the full entry |
| Betamethasone + Phenylephrine + Lignocainevia Bupivacaine | Major | Synergy | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as… | 3 sources — open the full entry |
| Calcium Dobesilate + Lidocaine + Dexamethasonevia Bupivacaine | Major | Synergy · Unknown | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as…2 documented mechanisms | 3 sources — open the full entry |
| Chloramphenicol + Lidocaine Hydrochloridevia Bupivacaine | Major | Synergy · Unknown | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as…2 documented mechanisms | 3 sources — open the full entry |
| Chloroquine Phosphatevia Bupivacaine | Major | Synergy | Coadministration of local anesthetics with other oxidizing agents that can also induce methemoglobinemia such as antimalarials (e.g., chloroquine, primaquine… | 5 sources — open the full entry |
| Cyclophosphamidevia Bupivacaine | Major | Synergy | Coadministration of local anesthetics with other oxidizing agents that can also induce methemoglobinemia such as antimalarials (e.g., chloroquine, primaquine… | 5 sources — open the full entry |
| Dapsonevia Bupivacaine | Major | Synergy | Coadministration of local anesthetics with other oxidizing agents that can also induce methemoglobinemia such as antimalarials (e.g., chloroquine, primaquine… | 5 sources — open the full entry |
| Diclofenac Sodium + Lidocaine Hydrochloridevia Bupivacaine | Major | Synergy · Unknown | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as…2 documented mechanisms | 3 sources — open the full entry |
| Flutamidevia Bupivacaine | Major | Synergy | Coadministration of local anesthetics with other oxidizing agents that can also induce methemoglobinemia such as antimalarials (e.g., chloroquine, primaquine… | 5 sources — open the full entry |
| Hydrocortisone + Lidocainevia Bupivacaine | Major | Synergy · Unknown | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as…2 documented mechanisms | 3 sources — open the full entry |
| Hydroxyureavia Bupivacaine | Major | Synergy | Coadministration of local anesthetics with other oxidizing agents that can also induce methemoglobinemia such as antimalarials (e.g., chloroquine, primaquine… | 5 sources — open the full entry |
| Ifosfamidevia Bupivacaine | Major | Synergy | Coadministration of local anesthetics with other oxidizing agents that can also induce methemoglobinemia such as antimalarials (e.g., chloroquine, primaquine… | 5 sources — open the full entry |
| Isosorbide Dinitrate + Hydralazine Hydrochloridevia Bupivacaine | Major | Synergy | Coadministration of local anesthetics with other oxidizing agents that can also induce methemoglobinemia such as antimalarials (e.g., chloroquine, primaquine… | 5 sources — open the full entry |
| Lidocaine + Adrenalinevia Bupivacaine | Major | Synergy · Unknown | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as…2 documented mechanisms | 3 sources — open the full entry |
| Lidocaine + Epinephrinevia Bupivacaine | Major | Synergy · Unknown | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as…2 documented mechanisms | 3 sources — open the full entry |
| Lidocaine + Prilocainevia Bupivacaine | Major | Synergy | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as…3 documented mechanisms | 16 sources — open the full entry |
| Lidocaine HydrochlorideInjectionSprayvia Bupivacaine | Major | Synergy | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as… | 3 sources — open the full entry |
| Nitrofurantoinvia Bupivacaine | Major | Synergy | Coadministration of local anesthetics with other oxidizing agents that can also induce methemoglobinemia such as antimalarials (e.g., chloroquine, primaquine… | 5 sources — open the full entry |
| Nitrofurantoin + Nitrofurantoin Microcrystalsvia Bupivacaine | Major | Synergy | Coadministration of local anesthetics with other oxidizing agents that can also induce methemoglobinemia such as antimalarials (e.g., chloroquine, primaquine… | 5 sources — open the full entry |
| Ofloxacin + Clotrimazole + Beclomethasone + Lidocainevia Bupivacaine | Major | Synergy | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as… | 3 sources — open the full entry |
| Phenobarbitalvia Bupivacaine | Major | Synergy | Coadministration of local anesthetics with other oxidizing agents that can also induce methemoglobinemia such as antimalarials (e.g., chloroquine, primaquine… | 5 sources — open the full entry |
| Primaquine Phosphatevia Bupivacaine | Major | Synergy | Coadministration of local anesthetics with other oxidizing agents that can also induce methemoglobinemia such as antimalarials (e.g., chloroquine, primaquine… | 5 sources — open the full entry |
| Quinine Sulfatevia Bupivacaine | Major | Synergy | Coadministration of local anesthetics with other oxidizing agents that can also induce methemoglobinemia such as antimalarials (e.g., chloroquine, primaquine… | 5 sources — open the full entry |
| Sulfasalazinevia Bupivacaine | Major | Synergy | Coadministration of local anesthetics with other oxidizing agents that can also induce methemoglobinemia such as antimalarials (e.g., chloroquine, primaquine… | 5 sources — open the full entry |
| Sulphamethoxazole + Trimethoprimvia Bupivacaine | Major | Synergy | Coadministration of local anesthetics with other oxidizing agents that can also induce methemoglobinemia such as antimalarials (e.g., chloroquine, primaquine…2 documented mechanisms | 5 sources — open the full entry |
| Tolperisone + Lidocainevia Bupivacaine | Major | Synergy | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as… | 3 sources — open the full entry |
| Tropicamide + Phenylephrine + Lidocainevia Bupivacaine | Major | Synergy | Additive toxicities may occur when bupivacaine is coadministered with other local anesthetics. The potential for increased risk of systemic toxicities such as… | 3 sources — open the full entry |
| Abametapirvia Bupivacaine | Moderate | Metabolism | Based on in vitro inhibition data, a single topical application of abametapir lotion may increase plasma concentrations of drugs that are substrates of CYP450… | 1 sources — open the full entry |
| Alprazolamvia Bupivacaine | Moderate | Synergy | The concomitant use of local anesthetics and benzodiazepines may have additive CNS-depressant effects. Both types of drugs are CNS depressants. | 7 sources — open the full entry |
| Amiodarone Hydrochloridevia Bupivacaine | Moderate | Synergy | Amide-type local anesthetics may have additive cardiac effects (e.g., bradycardia, chest pain, heart block, arrhythmias, ECG abnormalities, cardiac arrest)… | 2 sources — open the full entry |
| Amitriptyline Hydrochloride + Chlordiazepoxidevia Bupivacaine | Moderate | Synergy | The concomitant use of local anesthetics and benzodiazepines may have additive CNS-depressant effects. Both types of drugs are CNS depressants. | 7 sources — open the full entry |
| Amlodipine Besilate + Atenololvia Bupivacaine | Moderate | Synergy | Beta-blockers may increase the risk of bupivacaine-induced side effects. The proposed mechanism is increased bupivacaine levels due to hepatic enzyme… | 3 sources — open the full entry |
| Aprepitantvia Bupivacaine | Moderate | Metabolism | Coadministration with aprepitant or its prodrug, fosaprepitant, may increase the plasma concentrations of drugs that are primarily metabolized by CYP450 3A4… | 2 sources — open the full entry |
| Atenololvia Bupivacaine | Moderate | Synergy | Beta-blockers may increase the risk of bupivacaine-induced side effects. The proposed mechanism is increased bupivacaine levels due to hepatic enzyme… | 3 sources — open the full entry |
| Atenolol + Chlorthalidonevia Bupivacaine | Moderate | Synergy | Beta-blockers may increase the risk of bupivacaine-induced side effects. The proposed mechanism is increased bupivacaine levels due to hepatic enzyme… | 3 sources — open the full entry |
| Betaxolol Hydrochloridevia Bupivacaine | Moderate | Synergy | Beta-blockers may increase the risk of bupivacaine-induced side effects. The proposed mechanism is increased bupivacaine levels due to hepatic enzyme… | 3 sources — open the full entry |
| Bimatoprost + Timololvia Bupivacaine | Moderate | Synergy | Beta-blockers may increase the risk of bupivacaine-induced side effects. The proposed mechanism is increased bupivacaine levels due to hepatic enzyme… | 3 sources — open the full entry |
| Bisoprolol Fumaratevia Bupivacaine | Moderate | Synergy | Beta-blockers may increase the risk of bupivacaine-induced side effects. The proposed mechanism is increased bupivacaine levels due to hepatic enzyme… | 3 sources — open the full entry |
| Bisoprolol Fumarate + Amlodipine Besilatevia Bupivacaine | Moderate | Synergy | Beta-blockers may increase the risk of bupivacaine-induced side effects. The proposed mechanism is increased bupivacaine levels due to hepatic enzyme… | 3 sources — open the full entry |
| Bisoprolol Fumarate + Hydrochlorothiazidevia Bupivacaine | Moderate | Synergy · Unknown | Beta-blockers may increase the risk of bupivacaine-induced side effects. The proposed mechanism is increased bupivacaine levels due to hepatic enzyme…2 documented mechanisms | 3 sources — open the full entry |
| Brimonidine Tartrate + Timolol Maleatevia Bupivacaine | Moderate | Synergy | Beta-blockers may increase the risk of bupivacaine-induced side effects. The proposed mechanism is increased bupivacaine levels due to hepatic enzyme… | 3 sources — open the full entry |
| Brinzolamide + Timololvia Bupivacaine | Moderate | Synergy | Beta-blockers may increase the risk of bupivacaine-induced side effects. The proposed mechanism is increased bupivacaine levels due to hepatic enzyme… | 3 sources — open the full entry |
| Carvedilolvia Bupivacaine | Moderate | Synergy | Beta-blockers may increase the risk of bupivacaine-induced side effects. The proposed mechanism is increased bupivacaine levels due to hepatic enzyme… | 3 sources — open the full entry |
| Cinchocaine + Hydrocortisone + Framycetin + Esculinvia Bupivacaine | Moderate | Synergy · Unknown | Some topical anesthetics can be systemically absorbed and cause methemoglobinemia, particularly when applied to mucous membranes. Coadministration with other…2 documented mechanisms | 7 sources — open the full entry |
| Cinchocaine + Hydrocortisone + Neomycin + Esculinvia Bupivacaine | Moderate | Synergy · Unknown | Some topical anesthetics can be systemically absorbed and cause methemoglobinemia, particularly when applied to mucous membranes. Coadministration with other…2 documented mechanisms | 7 sources — open the full entry |
| Clobazamvia Bupivacaine | Moderate | Synergy | The concomitant use of local anesthetics and benzodiazepines may have additive CNS-depressant effects. Both types of drugs are CNS depressants. | 7 sources — open the full entry |
| Clonazepamvia Bupivacaine | Moderate | Synergy | The concomitant use of local anesthetics and benzodiazepines may have additive CNS-depressant effects. Both types of drugs are CNS depressants. | 7 sources — open the full entry |
| Diazepamvia Bupivacaine | Moderate | Synergy | The concomitant use of local anesthetics and benzodiazepines may have additive CNS-depressant effects. Both types of drugs are CNS depressants. | 7 sources — open the full entry |
Therapeutic duplication
Drug classes that overlap with Bupivacaine Hydrochloride + Dextrose, so taking both doubles up the same effect. This source publishes no per-row citations for duplication.
local injectable anesthetics
The recommended maximum number of medicines in the 'local injectable anesthetics' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'local injectable anesthetics' category.
Example product in the source data (US market): Epinephrine/prilocaine
local injectable anesthetics
The recommended maximum number of medicines in the 'local injectable anesthetics' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'local injectable anesthetics' category.
Example product in the source data (US market): Orabloc
local injectable anesthetics
The recommended maximum number of medicines in the 'local injectable anesthetics' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'local injectable anesthetics' category.
Example product in the source data (US market): Scandonest l
local injectable anesthetics
The recommended maximum number of medicines in the 'local injectable anesthetics' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'local injectable anesthetics' category.
Example product in the source data (US market): Epinephrine/lidocaine